Related Experiment Videos
Peroxisome proliferators and T3 operate by way of distinct receptors
H Castelein1, P E Declercq, G P Mannaerts
1Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Catholic University of Leuven, Belgium.
Abstract:
Peroxisome proliferators and thyroid hormones have a number of common metabolic effects. The possibility that the signal transduction pathways of both groups of effectors converge at the receptor level was investigated. It was shown that T3, specifically bound to the rat thyroid beta-receptor, was not displaced to a significant extent by ciprofibrate or bezafibrate. No specific binding of T3 to the mouse peroxisome proliferator activated receptor could be demonstrated. In transactivation experiments peroxisome proliferators were unable to activate the thyroid receptor and T3 did not activate a chimeric receptor containing the ligand binding domain of the peroxisome proliferator activated receptor. It is concluded that peroxisome proliferators and thyroid hormone do not cross-react at the level of their nuclear receptors.
Insights
Peroxisome proliferators and thyroid hormones do not interact at the nuclear receptor level. Studies show no cross-reactivity between these compounds and their respective receptors, indicating distinct signaling pathways.
Area of Science:
- Endocrinology
- Molecular Biology
- Toxicology
Background:
- Peroxisome proliferators and thyroid hormones share common metabolic effects.
- Investigating potential convergence of their signal transduction pathways at the receptor level is crucial for understanding their interactions.
Purpose of the Study:
- To determine if peroxisome proliferators and thyroid hormones cross-react at the nuclear receptor level.
- To elucidate the interaction between thyroid hormone receptors and peroxisome proliferator-activated receptors.
Main Methods:
- Ligand binding assays using rat thyroid beta-receptor and mouse peroxisome proliferator-activated receptor.
- Transactivation experiments to assess receptor activation by peroxisome proliferators and thyroid hormone.
Main Results:
- Thyroid hormone T3 did not show significant displacement from the rat thyroid beta-receptor by ciprofibrate or bezafibrate.
- No specific binding of T3 to the mouse peroxisome proliferator-activated receptor was observed.
- Peroxisome proliferators failed to activate the thyroid receptor, and T3 did not activate a chimeric receptor containing the peroxisome proliferator activated receptor ligand-binding domain.
Conclusions:
- Peroxisome proliferators and thyroid hormone do not cross-react at the level of their nuclear receptors.
- The distinct signaling pathways of peroxisome proliferators and thyroid hormones are maintained at the receptor level.